rel-Avibactam
rel-Avibactam (rel-NXL-104 free acid) is an isomer of Avibactam (HY-14879). Avibactam is a β-lactamase inhibitor with an IC50 of 8 nM against TEM-1 β-lactamase and an IC50 of 80 nM against P99 β-lactamase. Avibactam exhibits no significant intrinsic antibacterial activity when used alone. Avibactam restores the activity of Ceftazidime (HY-B0593) against β-lactamase-producing Enterobacteriaceae and Pseudomonas aeruginosa. Avibactam does not enhance the activity of Ceftazidime against Acinetobacter spp., Burkholderia spp., or most anaerobic Gram-negative bacilli. Avibactam is used in research related to Gram-negative bacterial infections.
For research use only. We do not sell to patients.
- CAS No.: 396731-14-9
- Formula: C7H11N3O6S
- Molecular Weight:265.24
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
Avibactam potently inhibits Ambler class A, class C, and some class D β-lactamases, with a turnover number of 1. It exhibits superior potency to existing β-lactamase inhibitors, with particularly prominent inhibitory activity against the KPC enzyme[1].
Avibactam (4 μg/mL) significantly enhances the in vitro activity of Ceftazidime (HY-B0593) against Enterobacteriaceae and Pseudomonas aeruginosa (including Ceftazidime-resistant strains), but does not potentiate the activity of Ceftazidime against Acinetobacter baumannii, Burkholderia cepacia, or Stenotrophomonas maltophilia[1].
Avibactam (4 μg/mL) enhances the in vitro activity of Ceftazidime against Prevotella/Porphyromonas species and Fusobacterium species, but does not enhance the activity of Ceftazidime against most Bacteroides species[1].
Avibactam (5 min) potently inhibits purified TEM-1 β-lactamase from Escherichia coli (IC50 = 8 nM) and purified P99 β-lactamase from Enterobacter cloacae 293HT6 (IC50 = 80 nM)[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
CAS No. 396731-14-9
-
Molecular Weight 265.24
-
Formula C7H11N3O6S
-
SMILES
NC([C@@H]1[N@]2C(N([C@](CC1)([H])C2)OS(=O)(O)=O)=O)=O
-
Synonyms
rel-NXL-104 free acid; rel-AVE1330A free acid
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Gram Staining of Tissue Sections
Gram staining of tissue sections is a histochemical technique used to differentiate Gram-positive and Gram-negative bacteria within histological specimens based on differences in bacterial cell wall structure and dye retention, adapted from classical bacteriological Gram staining into tissue-compatible “histological Gram stain” variants. In tissue applications, modifications of the Brown-Hopps and Brown-Brenn methods are commonly used to improve differentiation of microorganisms embedded within host connective tissue and to reduce overstaining or loss of Gram-negative signal, which are known limitations of earlier approaches. The principle relies on crystal violet-iodine complex retention in Gram-positive organisms and subsequent decolorization and counterstaining steps that allow contrast visualization of Gram-negative organisms against tissue background.
-
Bacterial live/dead nucleic-acid viability staining
The LIVE/DEAD bacterial viability staining method is based on differential permeability of nucleic-acid-binding fluorescent dyes, most commonly SYTO 9 and propidium iodide (PI), which enables discrimination of bacterial populations with intact versus compromised cytoplasmic membranes. SYTO 9 penetrates both intact and damaged bacterial membranes and binds nucleic acids to produce green fluorescence, whereas propidium iodide penetrates only cells with compromised membranes and fluoresces red while also reducing SYTO 9 signal through competitive binding and fluorescence interactions. The resulting fluorescence pattern is interpreted as a proxy for membrane integrity, which is widely used as an indicator of bacterial viability in microscopy, flow cytometry, and spectroscopic platforms. However, mechanistic studies show that SYTO 9 and PI interactions involve displacement and fluorescence resonance energy transfer effects, which can influence signal interpretation depending on dye ratios a
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- rel-Avibactam
- 396731-14-9
- rel-NXL-104
- rel-AVE1330A
- Beta-lactamase
- Bacterial
- Antibiotic
- Drug Isomer
- P99 β-lactamase
- Enterobacter cloacae
- Enterobacteriaceae
- Ambler class D β-lactamases
- Ambler class C β-lactamases
- Pseudomonas aeruginosa
- TEM-1 β-lactamase
- Ambler class A β-lactamases
- β-lactamase
- Escherichia coli
- Inhibitor
- inhibitor
- inhibit